Collective Data Harms at the Crossroads of Data Protection and Competition Law: Moving Beyond Individual Empowerment
European Business Law Review · 01.06.2022 · 33 (Issue 4) · 513-536
DOI: 10.54648/eulr2022024 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Business Law Review, erschienen am 01.06.2022. Verfasst von Inge Graef und 1 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
In an era of big data, harms caused by data technologies can no longer be effectively addressed under the predominant regulatory paradigm of individual empowerment. Even a sophisticated consumer cannot fully protect herself against collective harms triggered by others’ privacy choices or by technologies creating competitive harm without processing personal data or targeting individuals. While data protection and competition law can be applied more proactively to address such harms, difficulties are likely to remain. We therefore submit that stronger regulatory interventions are required to target collective, and sometimes competitive, harm from technologies like pervasive advertising, facial recognition, deepfakes and spyproducts. Big data, individual rights, societal harms, exploitative abuse, enforcement priorities, blacklists, pervasive advertising, facial recognition, deepfakes, spyproducts
Zitieren
APA
Graef, I., & Slot, B. V. D. (2022). Collective Data Harms at the Crossroads of Data Protection and Competition Law: Moving Beyond Individual Empowerment. European Business Law Review, 33(Issue 4), 513-536. https://doi.org/10.54648/eulr2022024
Vancouver
Graef I, Slot BVD. Collective Data Harms at the Crossroads of Data Protection and Competition Law: Moving Beyond Individual Empowerment. European Business Law Review. 2022;33(Issue 4):513-536. doi:10.54648/eulr2022024
BibTeX
@article{Graef2022,
author = {Graef, Inge and Slot, Bart van der},
title = {Collective Data Harms at the Crossroads of Data Protection and Competition Law: Moving Beyond Individual Empowerment},
journal = {European Business Law Review},
year = {2022},
volume = {33},
number = {Issue 4},
pages = {513--536},
doi = {10.54648/eulr2022024}
}
EUVIMED